Hello Yelrom, I am definitely not disappointed in the price or Novartis decision as it does not effect my financial situation in the slightest (and I’m grateful for this). I was just emphasising the fact that stem cell research is not an easy task to perfect as time has shown us and investors who do their homework should know this.There are many laws, regulations and corporations (government and private) to get around and this can take a lifetime. We all no that the treatment works, just not to the standard of those who don’t have the in-depth knowledge of the time and work involved to get it to work. Now to get it to a standard to those who don’t have the knowledge is going to take time, how long ? Who no’s. I will say that I am disappointed in the fact that these regulators know the research works with not one side and yet no approval, but approve others (vaccines) with many many side effects among tens of thousands of people and grant immediate approval. Makes a lot of us question our governances doesn’t it.As for Mr SI, he is not a people person never has been but there could be more effort in liaising with share holders whether it be him or someone else, this I agree with.
- Forums
- ASX - By Stock
- MSB Trading 2021 - paradigm shift
Hello Yelrom, I am definitely not disappointed in the price or...
- There are more pages in this discussion • 452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
0.070(6.45%) |
Mkt cap ! $1.318B |
Open | High | Low | Value | Volume |
$1.12 | $1.20 | $1.11 | $20.88M | 17.94M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 59978 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 34019 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 59978 | 1.150 |
9 | 317014 | 1.145 |
2 | 42121 | 1.140 |
8 | 119942 | 1.130 |
4 | 55950 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.155 | 25519 | 2 |
1.160 | 51465 | 2 |
1.165 | 57384 | 5 |
1.170 | 62000 | 4 |
1.180 | 14000 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.15 |
  |
Change
0.070 ( 5.63 %) |
|||
Open | High | Low | Volume | ||
$1.12 | $1.20 | $1.12 | 3733217 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online